Molecular Identity and Physiological Function of Novel Chloride Channels
Molecular Identity and Physiological Function of Novel Chloride Channels
批准号:
10406650
负责人:
Zhaozhu Qiu
金额:
$49.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-08-01 至 2027-07-31
关键词:
AcidosisAcidsAnimalsAnionsAreaBiologyCalcium ChannelCell DeathCell VolumesCellsCerebral IschemiaChloride ChannelsChloridesCryoelectron MicroscopyCystic FibrosisDiseaseDrug TargetingElectrophysiology (science)EnvironmentEpilepsyFamilyFluids and SecretionsFunctional disorderFundingGenetic DiseasesGoalsIn VitroInfectionInflammationIon ChannelIonsIschemic Brain InjuryKnockout MiceMalignant NeoplasmsMediatingMembrane ProteinsMolecularMolecular ConformationMutagenesisMyocardial IschemiaMyotoniaOrganellesPathologicPathway interactionsPhysiologicalPhysiologyPlayPotassium ChannelProtonsRNA interference screenRegulationResearchRoleSodium ChannelStrokeSwellingTimecell injuryfunctional genomicsimaging geneticsin vivointerdisciplinary approachmouse geneticsnovelpatch clampprogramsreceptorstructural biology
中文摘要
项目摘要/摘要
氯化物是动物细胞中含量最丰富的游离阴离子。氯离子通道发挥着广泛的功能
包括细胞体积调节、液体分泌、兴奋性调节和细胞内酸化
细胞器。许多与氯化物有关的遗传性疾病令人印象深刻地说明了它们的生理作用。
调节失调,如囊性纤维化、肌强直和癫痫。然而,尽管最近取得了进展,氯化物
长期以来,在离子通道的贵族家族中,通道一直是贫穷的表亲。几十年来,这一领域一直
以钠、钾和钙通道为主。事实上,仍然有许多电生理上的
特性良好的氯通道,没有分子同一性。这一差距使得我们不可能解释他们的
精确的功能以及它们的功能障碍如何导致疾病。在之前的R35 Mira ESI资助期,我们
进行了无偏RNAi筛选,鉴定了一种没有序列相似性的新的膜蛋白Pac
到其他离子通道,如长期受到追捧的酸或质子活化氯(PAC)通道。通过调解
氯离子内流和随后的细胞肿胀、PAC电流与酸诱导的细胞损伤有关。我们
建立PAC基因敲除小鼠并证明PAC在体外酸诱导的细胞死亡中起关键作用
和活体缺血性脑损伤。因此,PAC是治疗中风和其他酸中毒相关的潜在药物靶点。
疾病。通过结合突变、膜片钳记录和冷冻-EM,我们首次揭示了
三聚体组装,离子传导途径,阴离子选择性的基础,pH依赖的构象变化,
以及这一新通道的pH传感机制。一个新频道的发现代表着一项突破
开辟了一个新领域。未来5年,我们将重点关注PAC渠道的多元化监管机制
以及它在我们最近发现的囊泡酸化中令人惊讶的生理功能。长期的
此Mira计划的目标是应用多学科方法,包括高吞吐量功能
基因组学、膜片钳电生理学、结构生物学、成像和小鼠遗传学
氯离子通道生物学领域。
英文摘要
PROJECT SUMMARY/ABSTRACT
Chloride is the most abundant free anion in animal cells. Chloride channels play a wide range of functions
including cell volume regulation, fluid secretion, regulation of excitability, and acidification of intracellular
organelles. Their physiological role is impressively illustrated by many genetic diseases involving chloride
dysregulation, such as cystic fibrosis, myotonia, and epilepsy. However, despite recent progress, chloride
channels have long suffered as poor cousins in the aristocratic family of ion channels. For decades, the field has
been dominated by sodium, potassium and calcium channels. Indeed, there are still many electrophysiologically
well-characterized chloride channels without molecular identity. This gap makes it impossible to elucidate their
precise function and how their dysfunction leads to disease. In the previous R35 MIRA ESI funding period, we
performed an unbiased RNAi screen and identified PAC, a novel membrane protein with no sequence similarity
to other ion channels, as the long sought-after acid or proton-activated chloride (PAC) channel. By mediating
chloride influx and subsequent cell swelling, PAC currents have been implicated in acid-induced cell injury. We
generated PAC knockout mice and demonstrated that PAC plays a key role in acid-induced cell death in vitro
and ischemic brain injury in vivo. Thus, PAC is a potential drug target for stroke and other acidosis-associated
diseases. By combining mutagenesis, patch-clamp recording, and cryo-EM, we revealed for the first time the
trimeric assembly, ion conducting pathway, the basis of anion selectivity, pH-dependent conformational change,
and pH-sensing mechanism of this new channel. Discovery of a novel channel represents a breakthrough that
opens up a new field. In the next 5 years, we will focus on the diverse regulatory mechanisms of the PAC channel
and its surprising physiological function in vesicular acidification that we have recently discovered. The long-term
goal of this MIRA program is to apply a multi-disciplinary approach including high-throughput functional
genomics, patch-clamp electrophysiology, structural biology, imaging, and mouse genetics to the underexplored
area of chloride channel biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell Swelling-Activated Chloride Channel in Ischemic Stroke
-
批准号:10034096
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2020
-
负责人:Zhaozhu Qiu
-
依托单位:
Cell Swelling-Activated Chloride Channel in Ischemic Stroke
-
批准号:10388400
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2020
-
负责人:Zhaozhu Qiu
-
依托单位:
Cell Swelling-Activated Chloride Channel in Ischemic Stroke
-
批准号:10609492
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2020
-
负责人:Zhaozhu Qiu
-
依托单位:
Cell Swelling-Activated Chloride Channel in Ischemic Stroke
-
批准号:10208988
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2020
-
负责人:Zhaozhu Qiu
-
依托单位:
Cell Swelling-Activated Chloride Channel in Ischemic Stroke
-
批准号:10579414
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2020
-
负责人:Zhaozhu Qiu
-
依托单位:
Molecular Identity and Physiological Function of Novel Chloride Channels
-
批准号:10219298
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2017
-
负责人:Zhaozhu Qiu
-
依托单位:
Molecular Identity and Physiological Function of Novel Chloride Channels
-
批准号:10672411
-
项目类别:
-
资助金额:$49.13万
-
财政年份:2017
-
负责人:Zhaozhu Qiu
-
依托单位:
Molecular Identity and Physiological Function of Novel Chloride Channels
-
批准号:9381838
-
项目类别:
-
资助金额:$39.61万
-
财政年份:2017
-
负责人:Zhaozhu Qiu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: